Page 4 - Bun P News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bun p. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bun P Today - Breaking & Trending Today
The Nasdaq led losses among Wall Street's main indexes on Monday, with technology stocks taking a hit on concerns that the Federal Reserve will continue to hike interest rates after Friday's jobs data indicated a resilient labor market. ....
Wall Street's main indexes fell on Friday as investors fled from risky assets on growing concerns that a contagion in the banking sector had not been fully confined despite assurances from key officials. ....
SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the results of high-dose cohorts in a phase 1 clinical trial of mazdutide (IBI362), a glucagon-like petide-1 (GLP-1) and glucagon receptor dual agonist, in Chinese adults with overweight or obesity are presented as an on-demand poster (ODP014) at ENDO 2022. This randomized, double-blind, placebo-controlled multiple-ascending-dose study (ClinicalTrials.gov, NCT04440345) evaluated the safety, tolerability and PK/PD characteristics of mazdutide in Chinese participants with overweight or obesity. Twelve participants in each of the five cohorts were randomized 2:1 to receive subcutaneous 1.0-2.0-3.0 mg (cohort 1), 1.5-3.0-4.5 mg (cohort 2), 2.0-4.0-6.0 ....